Arbogast R C, White R S
Am Fam Physician. 1981 Jul;24(1):97-101.
IHSS is a familial illness with a significant and frequently lethal effect on cardiac function. Diagnosis can be made on clinical grounds and by echocardiography, and is confirmed by cardiac catheterization. High-dose beta -adrenergic blockade may control symptoms but does not give complete protection against fatal arrhythmias. Surgery may be required. A new class of drugs, calcium antagonists, will soon be marketed in this country and could provide more effective therapy for IHSS.
特发性肥厚性主动脉瓣下狭窄(IHSS)是一种家族性疾病,对心脏功能有显著且常为致命性的影响。可根据临床症状及超声心动图进行诊断,并通过心导管检查加以证实。大剂量β -肾上腺素能阻滞剂可控制症状,但不能完全预防致命性心律失常。可能需要进行手术。一类新型药物,即钙拮抗剂,不久将在该国上市,可能为特发性肥厚性主动脉瓣下狭窄提供更有效的治疗方法。